A pilot trial to assess the efficacy of Argatroban (Argatra) in critically ill patients with heparin resistance
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Argatroban (Primary) ; Heparin
- Indications Thromboembolism; Thrombosis
- Focus Therapeutic Use
- Acronyms ArgHeR
- 24 Jun 2016 Status changed from recruiting to completed.
- 16 Apr 2015 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2016, as reported by ClinicalTrials.gov.
- 26 Nov 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01734252).